Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:34 AM
Ignite Modification Date:
2025-12-25 @ 1:34 AM
NCT ID:
NCT03797794
Eligibility Criteria:
Inclusion Criteria:
* COPD patients, post-bronchodilator FEV1/FVC \<70% and FEV1 \<50% predicted
* oxygen saturation without suppletion \<=90% (home use of oxygen suppletion is allowed, but will be stopped during PESF-treatment)
* Stable medication (no foreseeable need to change therapy)
* Able to understand the purpose and method of research after adequate information and the ability to decide on participation
* Signed informed consent
Exclusion Criteria:
* Known malignant condition with limited life expectancy
* Carrier of electrical equipment (pacemaker, ICD etc)
* COPD exacerbation in the last 3 weeks
* Woman who are pregnant or of childbearing age without effective contraception
* Manifest acute infection
* Patients with manifest decompensatio cordis
* Rehabilitation/reactivation program within 2 months before or during the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Maximum Age:
85 Years
Study:
NCT03797794
Study Brief:
Protocol Section:
NCT03797794